Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?

Darryl Schuitevoerder, Irvan Bubic, Jeanine Fortino, Kristen Massimino, John Vetto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Completion lymph node dissection (CLND) for melanoma after positive sentinel lymph node biopsy (SLNB) was recently shown to improve regional but not overall survival, likely due to the majority of patients harboring no further nodal disease. We sought to determine predictors of non-sentinel node (NSN) positivity. Methods: Retrospective review of prospectively collected data on melanoma patients undergoing SLNB. Results: 116 patients underwent 119 CLNDs. The incidence of NSN positivity was 17.6%; the average number of positive NSNs in those cases was 1.5. Cervical and inguinofemoral location were most likely to yield positive NSN(s) (40% each). Conversely, the axilla was least likely at 18% (p < 0.001). The average number of nodes harvested was 13 for NSN negative cases and 20 for NSN positive cases (p = 0.005). Tumor thickness increased the probability of positive NSN(s) (OR 1.2, p = 0.02). Conclusions: Tumor thickness and nodal basin were predictors of NSN metastasis, factors that could help determine which patients may benefit from CLND. Further, CLNDs with fewer nodes may inadequately clear residual nodal disease.

Original languageEnglish (US)
JournalAmerican Journal of Surgery
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Lymph Node Excision
Melanoma
Sentinel Lymph Node Biopsy
Axilla
Neoplasms
Neoplasm Metastasis
Survival
Sentinel Lymph Node
Incidence

Keywords

  • Completion lymph node dissection
  • Melanoma
  • Non-sentinel lymph node
  • Sentinel node

ASJC Scopus subject areas

  • Surgery

Cite this

Patients with sentinel lymph node positive melanoma : Who needs completion lymph node dissection? / Schuitevoerder, Darryl; Bubic, Irvan; Fortino, Jeanine; Massimino, Kristen; Vetto, John.

In: American Journal of Surgery, 01.01.2018.

Research output: Contribution to journalArticle

Schuitevoerder, Darryl ; Bubic, Irvan ; Fortino, Jeanine ; Massimino, Kristen ; Vetto, John. / Patients with sentinel lymph node positive melanoma : Who needs completion lymph node dissection?. In: American Journal of Surgery. 2018.
@article{afdb8a580ea943e9b52ff8fdd7f5aa43,
title = "Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?",
abstract = "Introduction: Completion lymph node dissection (CLND) for melanoma after positive sentinel lymph node biopsy (SLNB) was recently shown to improve regional but not overall survival, likely due to the majority of patients harboring no further nodal disease. We sought to determine predictors of non-sentinel node (NSN) positivity. Methods: Retrospective review of prospectively collected data on melanoma patients undergoing SLNB. Results: 116 patients underwent 119 CLNDs. The incidence of NSN positivity was 17.6{\%}; the average number of positive NSNs in those cases was 1.5. Cervical and inguinofemoral location were most likely to yield positive NSN(s) (40{\%} each). Conversely, the axilla was least likely at 18{\%} (p < 0.001). The average number of nodes harvested was 13 for NSN negative cases and 20 for NSN positive cases (p = 0.005). Tumor thickness increased the probability of positive NSN(s) (OR 1.2, p = 0.02). Conclusions: Tumor thickness and nodal basin were predictors of NSN metastasis, factors that could help determine which patients may benefit from CLND. Further, CLNDs with fewer nodes may inadequately clear residual nodal disease.",
keywords = "Completion lymph node dissection, Melanoma, Non-sentinel lymph node, Sentinel node",
author = "Darryl Schuitevoerder and Irvan Bubic and Jeanine Fortino and Kristen Massimino and John Vetto",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.amjsurg.2018.01.033",
language = "English (US)",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Patients with sentinel lymph node positive melanoma

T2 - Who needs completion lymph node dissection?

AU - Schuitevoerder, Darryl

AU - Bubic, Irvan

AU - Fortino, Jeanine

AU - Massimino, Kristen

AU - Vetto, John

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: Completion lymph node dissection (CLND) for melanoma after positive sentinel lymph node biopsy (SLNB) was recently shown to improve regional but not overall survival, likely due to the majority of patients harboring no further nodal disease. We sought to determine predictors of non-sentinel node (NSN) positivity. Methods: Retrospective review of prospectively collected data on melanoma patients undergoing SLNB. Results: 116 patients underwent 119 CLNDs. The incidence of NSN positivity was 17.6%; the average number of positive NSNs in those cases was 1.5. Cervical and inguinofemoral location were most likely to yield positive NSN(s) (40% each). Conversely, the axilla was least likely at 18% (p < 0.001). The average number of nodes harvested was 13 for NSN negative cases and 20 for NSN positive cases (p = 0.005). Tumor thickness increased the probability of positive NSN(s) (OR 1.2, p = 0.02). Conclusions: Tumor thickness and nodal basin were predictors of NSN metastasis, factors that could help determine which patients may benefit from CLND. Further, CLNDs with fewer nodes may inadequately clear residual nodal disease.

AB - Introduction: Completion lymph node dissection (CLND) for melanoma after positive sentinel lymph node biopsy (SLNB) was recently shown to improve regional but not overall survival, likely due to the majority of patients harboring no further nodal disease. We sought to determine predictors of non-sentinel node (NSN) positivity. Methods: Retrospective review of prospectively collected data on melanoma patients undergoing SLNB. Results: 116 patients underwent 119 CLNDs. The incidence of NSN positivity was 17.6%; the average number of positive NSNs in those cases was 1.5. Cervical and inguinofemoral location were most likely to yield positive NSN(s) (40% each). Conversely, the axilla was least likely at 18% (p < 0.001). The average number of nodes harvested was 13 for NSN negative cases and 20 for NSN positive cases (p = 0.005). Tumor thickness increased the probability of positive NSN(s) (OR 1.2, p = 0.02). Conclusions: Tumor thickness and nodal basin were predictors of NSN metastasis, factors that could help determine which patients may benefit from CLND. Further, CLNDs with fewer nodes may inadequately clear residual nodal disease.

KW - Completion lymph node dissection

KW - Melanoma

KW - Non-sentinel lymph node

KW - Sentinel node

UR - http://www.scopus.com/inward/record.url?scp=85041298515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041298515&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2018.01.033

DO - 10.1016/j.amjsurg.2018.01.033

M3 - Article

C2 - 29397888

AN - SCOPUS:85041298515

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

ER -